Long Term Effects of the Low FODMAP Diet

  • Research type

    Research Study

  • Full title

    Long Term Effects of the Low FODMAP Diet

  • IRAS ID

    256181

  • Contact name

    David Sanders

  • Contact email

    David.Sanders@sth.nhs.uk

  • Sponsor organisation

    Sheffield Teaching Hospitals NHS FT

  • Duration of Study in the UK

    1 years, 2 months, 1 days

  • Research summary

    Irritable bowel syndrome is common, with a reported pooled prevalence of 11% globally. Irritable bowel syndrome can have a significant harmful effect in the long term, including increased time off work and reduction in quality of life. Diet appears to be pivotal in symptom generation in patients with Irritable bowel syndrome, with up to two thirds of individuals developing symptoms after the ingestion of food. As a result of this, there has been a great interest in dietary therapies for this condition, with several double-blind placebo controlled trials and randomised controlled trials evaluating these therapies to date. Despite these there remain a number of unanswered questions of dietary therapies in Irritable bowel syndrome. We would like to assess these further, with a focus on the long term adherence to dietary therapies in Irritable bowel syndrome and effect of dietary therapies on socialising. Participants will comprise of individuals with Irritable bowel syndrome or presenting with symptoms, this study will aim to analyse the outcomes of these patients.

    The aim of the study is to assess long term adherence to a low in fermentable oligo, di, mono-saccharides and polyols (FODMAP) diet and the effect of the low FODMAP diet on socialising. Participants will be recruited to this observational study, being identified as those who have been referred to secondary care dietetic services at Sheffield Teaching Hospitals for consideration of dietary therapies in Irritable bowel syndrome / Irritable bowel syndrome type symptoms. The study will collect questionnaire data and medical data, participants will be followed up in line with standard care for 6 months.

  • REC name

    London - Chelsea Research Ethics Committee

  • REC reference

    18/LO/2234

  • Date of REC Opinion

    3 Jan 2019

  • REC opinion

    Favourable Opinion